KEVIN F MCLAUGHLIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN F MCLAUGHLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN F MCLAUGHLIN. KEVIN F MCLAUGHLIN is in Vericel Corp ($ASTM) and Director in Vericel Corp ($ASTM) and Executive V.P. and C.F.O. in PRAECIS PHARMACEUTICALS INC ($PRCS) and President & COO in PRAECIS PHARMACEUTICALS INC ($PRCS) and President and CEO in PRAECIS PHARMACEUTICALS INC ($PRCS) and President, COO & Secretary in PRAECIS PHARMACEUTICALS INC ($PRCS) and Senior V.P. and C.F.O. in PRAECIS PHARMACEUTICALS INC ($PRCS) and Senior Vice President & CFO in PRAECIS PHARMACEUTICALS INC ($PRCS) and Senior VP and CFO in PRAECIS PHARMACEUTICALS INC ($PRCS) and SVP, CFO and Treasurer in ACCELERON PHARMA INC ($XLRN).
Latest Insider Trading Transactions of KEVIN F MCLAUGHLIN
Sentiment: All, XLRN, PRCS, ASTM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 1,500 | 5,820 | 41,500 | 40 K to 41.5 K (+3.75 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 31.07 | 1,293 | 40,174 | 40,000 | 41.3 K to 40 K (-3.13 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 30.22 | 2,500 | 75,550 | 41,293 | 43.8 K to 41.3 K (-5.71 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 29.11 | 1,207 | 35,136 | 43,793 | 45 K to 43.8 K (-2.68 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 45,000 | 40 K to 45 K (+12.50 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 1,500 | 5,820 | 42,251 | |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 43,751 | |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 28.54 | 1,500 | 42,810 | 40,000 | 41.5 K to 40 K (-3.61 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 1,500 | 5,820 | 41,500 | 40 K to 41.5 K (+3.75 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 29.23 | 100 | 2,923 | 40,000 | 40.1 K to 40 K (-0.25 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 28.51 | 4,900 | 139,699 | 40,100 | 45 K to 40.1 K (-10.89 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 45,000 | 40 K to 45 K (+12.50 %) |
| Jul 30 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 48,751 | |
| Jul 30 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 40,000 | 35 K to 40 K (+14.29 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 53,751 | |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 55,751 | |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 30.39 | 95 | 2,887 | 35,000 | 35.1 K to 35 K (-0.27 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 29.68 | 1,905 | 56,540 | 35,095 | 37 K to 35.1 K (-5.15 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 2,000 | 7,760 | 37,000 | 35 K to 37 K (+5.71 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 30.27 | 377 | 11,412 | 35,000 | 35.4 K to 35 K (-1.07 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 29.65 | 4,623 | 137,072 | 35,377 | 40 K to 35.4 K (-11.56 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 40,000 | 35 K to 40 K (+14.29 %) |
| Jun 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 60,751 | |
| Jun 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 35,000 | 30 K to 35 K (+16.67 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 1,500 | 5,820 | 65,751 | |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 67,251 | |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 32.96 | 200 | 6,592 | 30,000 | 30.2 K to 30 K (-0.66 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 32.37 | 1,300 | 42,081 | 30,200 | 31.5 K to 30.2 K (-4.13 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 1,500 | 5,820 | 31,500 | 30 K to 31.5 K (+5.00 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 32.97 | 100 | 3,297 | 30,000 | 30.1 K to 30 K (-0.33 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 32.49 | 4,900 | 159,201 | 30,100 | 35 K to 30.1 K (-14.00 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 35,000 | 30 K to 35 K (+16.67 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 72,251 | |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 6,500 | 25,220 | 77,251 | |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 30,000 | 25 K to 30 K (+20.00 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 31.78 | 1,500 | 47,670 | 25,000 | 26.5 K to 25 K (-5.66 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 32.40 | 100 | 3,240 | 26,500 | 26.6 K to 26.5 K (-0.38 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 31.79 | 4,900 | 155,771 | 26,600 | 31.5 K to 26.6 K (-15.56 %) |
| May 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 6,500 | 25,220 | 31,500 | 25 K to 31.5 K (+26.00 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 83,751 | |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 88,751 | |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 35.50 | 500 | 17,750 | 25,000 | 25.5 K to 25 K (-1.96 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 34.80 | 4,500 | 156,600 | 25,500 | 30 K to 25.5 K (-15.00 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 30,000 | 25 K to 30 K (+20.00 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 35.52 | 250 | 8,880 | 25,000 | 25.3 K to 25 K (-0.99 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 34.82 | 1,750 | 60,935 | 25,250 | 27 K to 25.3 K (-6.48 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 2,000 | 7,760 | 27,000 | 25 K to 27 K (+8.00 %) |
| Mar 24 2015 | ASTM | Vericel Corp | MCLAUGHLIN KEVIN F | Director | Option Exercise | A | 3.74 | 20,000 | 74,800 | 20,000 | |
| Mar 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 1,500 | 5,820 | 90,751 | |
| Mar 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 92,251 | |
| Mar 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 40.94 | 200 | 8,188 | 25,000 | 25.2 K to 25 K (-0.79 %) |
| Mar 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 40.14 | 1,300 | 52,182 | 25,200 | 26.5 K to 25.2 K (-4.91 %) |
| Mar 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 1,500 | 5,820 | 26,500 | 25 K to 26.5 K (+6.00 %) |
| Mar 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 40.93 | 619 | 25,336 | 25,000 | 25.6 K to 25 K (-2.42 %) |
| Mar 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 40.16 | 4,381 | 175,941 | 25,619 | 30 K to 25.6 K (-14.60 %) |
| Mar 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 30,000 | 25 K to 30 K (+20.00 %) |
| Feb 08 2007 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | President and CEO | Option Exercise | D | 3.35 | 80,000 | 268,000 | 0 | |
| Feb 08 2007 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | President and CEO | Sell | U | 5.00 | 45,000 | 225,000 | 0 | 45 K to 0 (-100.00 %) |
| Sep 05 2006 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | President and CEO | Option Exercise | M | 1.33 | 24,200 | 32,186 | 0 | |
| Sep 05 2006 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | President and CEO | Buy | M | 1.33 | 24,200 | 32,186 | 45,000 | 20.8 K to 45 K (+116.35 %) |
| Jun 01 2005 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | President and CEO | Option Exercise | A | 0.67 | 400,000 | 268,000 | 400,000 | |
| Nov 15 2004 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | President & COO | Option Exercise | A | 1.86 | 108,000 | 200,880 | 108,000 | |
| Sep 17 2004 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | President, COO & Se ... | Option Exercise | A | 2.22 | 50,000 | 111,000 | 50,000 | |
| Feb 09 2004 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Executive V.P. and ... | Option Exercise | M | 0.27 | 10,000 | 2,700 | 121,000 | |
| Feb 09 2004 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Executive V.P. and ... | Buy | M | 0.27 | 10,000 | 2,700 | 104,000 | 94 K to 104 K (+10.64 %) |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Option Exercise | M | 0.27 | 25,000 | 6,750 | 133,000 | |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Sell | S | 7.55 | 1,500 | 11,325 | 92,000 | 93.5 K to 92 K (-1.60 %) |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Sell | S | 7.54 | 5,800 | 43,732 | 93,500 | 99.3 K to 93.5 K (-5.84 %) |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Sell | S | 7.53 | 2,200 | 16,566 | 99,300 | 101.5 K to 99.3 K (-2.17 %) |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Sell | S | 7.52 | 2,700 | 20,304 | 101,500 | 104.2 K to 101.5 K (-2.59 %) |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Sell | S | 7.50 | 7,800 | 58,500 | 104,200 | 112 K to 104.2 K (-6.96 %) |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Sell | S | 7.49 | 5,000 | 37,450 | 112,000 | 117 K to 112 K (-4.27 %) |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Sell | S | 7.44 | 1,100 | 8,184 | 117,000 | 118.1 K to 117 K (-0.93 %) |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Sell | S | 7.43 | 2,700 | 20,061 | 118,100 | 120.8 K to 118.1 K (-2.24 %) |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Sell | S | 7.41 | 100 | 741 | 120,800 | 120.9 K to 120.8 K (-0.08 %) |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Sell | S | 7.40 | 1,600 | 11,842 | 120,900 | 122.5 K to 120.9 K (-1.31 %) |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Sell | S | 7.40 | 4,500 | 33,300 | 122,500 | 127 K to 122.5 K (-3.54 %) |
| Dec 03 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior VP and CFO | Buy | M | 0.27 | 25,000 | 6,750 | 127,000 | 102 K to 127 K (+24.51 %) |
| Dec 30 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior V.P. and C.F ... | Option Exercise | M | 0.27 | 2,000 | 540 | 131,000 | |
| Dec 30 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior V.P. and C.F ... | Buy | M | 0.27 | 2,000 | 540 | 94,000 | 92 K to 94 K (+2.17 %) |
| Nov 14 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior Vice Preside ... | Option Exercise | A | 6.68 | 87,500 | 584,500 | 87,500 | |
| Nov 14 2003 | PRCS | PRAECIS PHARMACEUT ... | MCLAUGHLIN KEVIN F | Senior Vice Preside ... | Option Exercise | A | 6.68 | 87,500 | 584,500 | 87,500 |